Letter to the Editor in response to 'N Folschweiller, V Berlaimont, SR Skinner, CM Wheeler, N Karkada, F Struyf, M Ryser. Letter to the Editor in response to OM Bautista, A. Luxembourg. Deconstructing the measure of vaccine efficacy against disease irrespective of HPV in HPV vaccine clinical trials. Contemp. Clin. Trials (2016), doi: 10.1016/j.cct.2016.12.022'

Bautista Oliver M.; Luxembourg Alain

首页> 外文期刊>Contemporary clinical trials >Letter to the Editor in response to 'N Folschweiller, V Berlaimont, SR Skinner, CM Wheeler, N Karkada, F Struyf, M Ryser. Letter to the Editor in response to OM Bautista, A. Luxembourg. Deconstructing the measure of vaccine efficacy against disease irrespective of HPV in HPV vaccine clinical trials. Contemp. Clin. Trials (2016), doi: 10.1016/j.cct.2016.12.022'

【24h】

Letter to the Editor in response to 'N Folschweiller, V Berlaimont, SR Skinner, CM Wheeler, N Karkada, F Struyf, M Ryser. Letter to the Editor in response to OM Bautista, A. Luxembourg. Deconstructing the measure of vaccine efficacy against disease irrespective of HPV in HPV vaccine clinical trials. Contemp. Clin. Trials (2016), doi: 10.1016/j.cct.2016.12.022'

机译：响应“N Folschweiller，VErlaimont，SR Skinner，CM Wheeler，N Karkada，F Struyf，M卢塞尔的信函。回复OM Bautista，A.卢森堡的信函。解构疫苗疗效的衡量标准疾病无论HPV疫苗临床试验中的HPV如何。CONTEMP。CLIN。试验（2016），DOI：10.1016 / J.CCT.2016.12.022“

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Contemporary clinical trials》 |2017年第2017期|共1页
作者
Bautista Oliver M.; Luxembourg Alain;
展开▼
作者单位

Merck &

Co Inc Kenilworth NJ 07033 USA;

Merck &

Co Inc Kenilworth NJ 07033 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类诊断学;
关键词

相似文献

外文文献

1. Letter to the Editor in response to "N Folschweiller, V Berlaimont, SR Skinner, CM Wheeler, N Karkada, F Struyf, M Ryser. Letter to the Editor in response to OM Bautista, A. Luxembourg. Deconstructing the measure of vaccine efficacy against disease irrespective of HPV in HPV vaccine clinical trials. Contemp. Clin. Trials (2016), doi: 10.1016/j.cct.2016.12.022" [J] . Bautista Oliver M., Luxembourg Alain Contemporary clinical trials . 2017,第期

机译：响应“N Folschweiller，VErlaimont，SR Skinner，CM Wheeler，N Karkada，F Struyf，M卢塞尔的信函。回复OM Bautista，A.卢森堡的信函。解构疫苗疗效的衡量标准疾病无论HPV疫苗临床试验中的HPV如何。CONTEMP。CLIN。试验（2016），DOI：10.1016 / J.CCT.2016.12.022“
2. Deconstructing the measure of vaccine efficacy against disease irrespective of HPV in HPV vaccine clinical trials [J] . Oliver M. Bautista, Bautista, Alain Luxembourg, Contemporary clinical trials . 2016,第1期

机译：不论HPV疫苗临床试验中HPV如何解构疫苗疗效的措施
3. Letter-to-the-Editor in response to “Tanton C, et al. Human papillomavirus (HPV) in young women in Britain: Population-based evidence ofthe effectiveness of the bivalent immunisation programme and burden of quadrivalent and 9-valent vaccine types. Papillomavirus Res. 2017 Jun;3:36-41.doi: 10.1016/j.pvr.2017.01.001.” [J] . Martin Ryser, Adrienne Guignard, Valérie Berlaimont Papillomavirus Research . 2018,第1期

机译：写给编辑的信，回应“ Tanton C等人。英国年轻女性中的人乳头瘤病毒（HPV）：基于人群的二价免疫计划有效性以及四价和9价疫苗类型负担的证据。乳头瘤病毒Res。 2017年6月; 3：36-41.doi：10.1016 / j.pvr.2017.01.001。”
4. Letter-to-the-Editor in response to “Tanton C, et al. Human papillomavirus (HPV) in young women in Britain: Population-based evidence ofthe effectiveness of the bivalent immunisation programme and burden of quadrivalent and 9-valent vaccine types. Papillomavirus Res. 2017 Jun;3:36-41.doi: 10.1016/j.pvr.2017.01.001.” [O] . Martin Ryser, Adrienne Guignard, Valérie Berlaimont 2012

机译：致编辑的信，回应“ Tanton C等人。英国年轻女性中的人乳头瘤病毒（HPV）：基于人群的二价免疫计划有效性以及四价和9价疫苗类型负担的证据。乳头瘤病毒Res。 2017年6月； 3：36-41.doi：10.1016 / j.pvr.2017.01.001。”
5. Letter-to-the-Editor in response to “Tanton C, et al. Human papillomavirus (HPV) in young women in Britain: Population-based evidence ofthe effectiveness of the bivalent immunisation programme and burden of quadrivalent and 9-valent vaccine types. Papillomavirus Res. 2017 Jun;3:36-41.doi: 10.1016/j.pvr.2017.01.001.” [O] . Martin Ryser, Adrienne Guignard, Valérie Berlaimont 2018

机译：响应“Tanton C，et al”的信件到编辑器。人乳头瘤病毒（HPV）在英国的年轻女性：基于人口的证据证明二价免疫计划的有效性和四价疫苗类型的疗效。乳头瘤病毒res。 2017年6月3：36-41.DOI：10.1016 / J.PVR.2017.01.001。“

著录项

相似文献

相关主题

期刊订阅